---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-24-000082"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:16:50.346461+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "medium"
source: SEC EDGAR
---

# CEO Joseph Woody retires; CFO Michael Greiner named interim CEO; Warren Machan interim CFO

## Summary
- Joseph Woody retired as CEO and board member effective Oct 28, 2024; will consult through Apr 30, 2025 at $84,618/month.
- Michael Greiner (SVP/CFO/CTO) appointed interim CEO; receives $600k salary, $83k/month stipend, and $1M RSU grant.
- Warren Machan (former SVP Business Strategy) appointed interim CFO; compensation not yet determined.
- Board will conduct a search for permanent CEO; Greiner is leading candidate but will evaluate other candidates.
- Company reported Q3 2024 financial results via press release on Oct 30; specific figures not included in this filing.

## SEC filing metadata
- accession: 0001606498-24-000082
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: medium
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000082/0001606498-24-000082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000082/avns-20241028.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-24-000082
- JSON: https://secwatch.observer/filing/0001606498-24-000082.json
- Plain text: https://secwatch.observer/filing/0001606498-24-000082.txt

## Key facts
- Executive change
  Michael C. Greiner was appointed as Interim Chief Executive Officer at AVANOS MEDICAL, INC..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: the Company appointed Michael C. Greiner to serve as Interim Chief Executive Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000082/0001606498-24-000082-index.htm
- Executive change
  Joseph F. Woody retired as Chief Executive Officer at AVANOS MEDICAL, INC..
  - Action: retired
  - Role: Chief Executive Officer
  source text: On October 28, 2024, the Company announced the retirement of Joseph F. Woody as Chief Executive Officer and a member of the Board of Directors of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000082/0001606498-24-000082-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.